How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,447 results for

Intrauterine Growth Retardation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Choline supplementation improves the lipid metabolism of intrauterine-growth-restricted pigs Full Text available with Trip Pro

Choline supplementation improves the lipid metabolism of intrauterine-growth-restricted pigs The objective of this study was to investigate the effects of dietary choline supplementation on hepatic lipid metabolism and gene expression in finishing pigs with intrauterine growth retardation (IUGR).Using a 2×2 factorial design, eight normal birth weight (NBW) and eight IUGR weaned pigs were fed either a basal diet (NBW pigs fed a basal diet, NC; IUGR pigs fed a basal diet, IC) or a diet

2016 Asian-Australasian journal of animal sciences

62. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects Full Text available with Trip Pro

. SGA has been defined as having birth weight less than two standard deviations below the mean or less than the 10th percentile of a population-specific birth weight for specific gestational age. These infants have many acute neonatal problems that include perinatal asphyxia, hypothermia, hypoglycemia, and polycythemia. The likely long-term complications that are prone to develop when IUGR infants grow up includes growth retardation, major and subtle neurodevelopmental handicaps, and developmental (...) Intrauterine Growth Restriction: Antenatal and Postnatal Aspects Intrauterine growth restriction (IUGR), a condition that occurs due to various reasons, is an important cause of fetal and neonatal morbidity and mortality. It has been defined as a rate of fetal growth that is less than normal in light of the growth potential of that specific infant. Usually, IUGR and small for gestational age (SGA) are used interchangeably in literature, even though there exist minute differences between them

2016 Clinical medicine insights. Pediatrics

63. Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction

Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction (GROWTH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02672566 Recruitment Status : Recruiting First Posted : February 3

2016 Clinical Trials

64. Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction

Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02678221 Recruitment Status : Unknown Verified February 2016 by Omar Mamdouh Shaaban, Assiut University. Recruitment status was: Not yet recruiting First

2016 Clinical Trials

65. The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction

The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02696577 Recruitment Status : Completed First Posted : March 2, 2016 Last Update Posted : March 15, 2016 Sponsor: Assiut

2016 Clinical Trials

66. First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction

volume First-trimester screening Ultrasound Preeclampsia Intrauterine growth restriction Biochemical markers Uterine artery doppler Additional relevant MeSH terms: Layout table for MeSH terms Pre-Eclampsia Fetal Growth Retardation Hypertension, Pregnancy-Induced Pregnancy Complications Fetal Diseases Growth Disorders Pathologic Processes Angiogenesis Inhibitors Angiogenesis Inducing Agents Angiogenesis Modulating Agents Growth Substances Physiological Effects of Drugs Growth Inhibitors Antineoplastic (...) First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2016 Clinical Trials

67. Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. Full Text available with Trip Pro

Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. 27573023 2017 03 20 2017 05 05 1651-2057 97 3 2017 03 10 Acta dermato-venereologica Acta Derm. Venereol. Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. 410-411 10.2340/00015555-2527 Saito-Sasaki Natsuko N Department of Dermatology, University of Occupational and Environmental (...) Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu , 807-8555, Japan. natsuko-saito@med.uoeh-u.ac.jp. Izu Kunio K Sawada Yu Y Hino Ryosuke R Nakano Ryoji R Shimajiri Shohei S Nishimura Izumi I Nakamura Hiromasa H Sugiura Kazumitsu K Nakamura Motonobu M eng Case Reports Journal Article Sweden Acta Derm Venereol 0370310 0001-5555 IM Biopsy Dermatitis Herpetiformis blood diagnosis therapy Female Fetal Growth Retardation blood diagnosis immunology therapy Granulocytes immunology Humans Impetigo blood

2016 Acta Dermato-Venereologica

68. Evaluation of Infants With Intrauterine Growth Restriction

Study ID Numbers: 142 /181/ 20.05.2014 First Posted: August 4, 2015 Last Update Posted: August 6, 2015 Last Verified: August 2015 Keywords provided by Hășmășanu Monica Gabriela, Iuliu Hatieganu University of Medicine and Pharmacy: IUGR (intrauterine growth restriction) IGF2 (insulin-like growth factor 2) morbidity Additional relevant MeSH terms: Layout table for MeSH terms Fetal Growth Retardation Fetal Diseases Pregnancy Complications Growth Disorders Pathologic Processes (...) Evaluation of Infants With Intrauterine Growth Restriction Evaluation of Infants With Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Evaluation of Infants With Intrauterine

2015 Clinical Trials

69. Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction

Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (STRIDER Canada) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02442492 Recruitment Status : Suspended (STRIDER-Canada trial suspended recruitment until further information can be obtained following

2015 Clinical Trials

70. Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates

Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Leukemia Inhibitory Factor Level in Intrauterine Growth Restriction Neonates The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02518126 Recruitment Status : Unknown Verified August 2015 by Rambam Health Care Campus. Recruitment status was: Not yet recruiting First Posted : August 7, 2015 Last Update

2015 Clinical Trials

71. Trial on the Impact of Technical Anesthetic in Pregnancies With Intrauterine Growth Restriction

Trial on the Impact of Technical Anesthetic in Pregnancies With Intrauterine Growth Restriction Trial on the Impact of Technical Anesthetic in Pregnancies With Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. Trial on the Impact of Technical Anesthetic in Pregnancies With Intrauterine Growth Restriction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02666794 Recruitment Status : Recruiting

2015 Clinical Trials

72. LOSS OF METHYLATION AT GNAS EXON A/B IS ASSOCIATED WITH INCREASED INTRAUTERINE GROWTH. Full Text available with Trip Pro

of methylation (LOM) at exon A/B alone or sporadic PHP1B (sporPHP1B) associated with broad GNAS methylation changes. Similar to effects other imprinted genes have on early development, we recently observed severe intrauterine growth retardation in newborns, later diagnosed with pseudopseudohypoparathyroidism (PPHP) because of paternal GNAS loss-of-function mutations.This study aimed to determine whether GNAS methylation abnormalities affect intrauterine growth.Birth parameters were collected of patients who (...) LOSS OF METHYLATION AT GNAS EXON A/B IS ASSOCIATED WITH INCREASED INTRAUTERINE GROWTH. GNAS is one of few genetic loci that undergo allelic-specific methylation resulting in the parent-specific expression of at least four different transcripts. Due to monoallelic expression, heterozygous GNAS mutations affecting either paternally or maternally derived transcripts cause different forms of pseudohypoparathyroidism (PHP), including autosomal-dominant PHP type Ib (AD-PHP1B) associated with loss

2015 Journal of Clinical Endocrinology and Metabolism

73. Morphology of early intrauterine deaths with full trisomy 15. (Abstract)

miscarriages, and no case of full trisomy 15 was observed in 62 fetal miscarriages. Fifty-eight embryos with full trisomy 15 showed structural defects on embryoscopic examination. The most common defects were craniofacial anomalies (n = 73), retarded development of the limbs (n = 39), and abnormally short umbilical cords closely attaching the embryo to the chorionic plate (n = 27). Seven embryos were classified as growth disorganized. Limb reduction defects with a prevalence of 5.6/10 000 births, all (...) Morphology of early intrauterine deaths with full trisomy 15. The morphologic features of embryos with full trisomy 15 are described.A total of 1195 pregnancy losses were examined embryoscopically and cytogenetically.Of 1173 successfully karyotyped specimens, full trisomy 15 was diagnosed cytogenetically in 59 cases (5%). All 59 trisomy 15 embryos were diagnosed cytogenetically in the group of 962 embryonic miscarriages (6%). Trisomy 15 was not registered in 171 anembryonic or yolk sac

2018 Prenatal diagnosis

74. Glucocorticoid mediates prenatal caffeine exposure-induced endochondral ossification retardation and its molecular mechanism in female fetal rats Full Text available with Trip Pro

Glucocorticoid mediates prenatal caffeine exposure-induced endochondral ossification retardation and its molecular mechanism in female fetal rats Our previous studies discovered that prenatal caffeine exposure (PCE) could induce intrauterine growth retardation (IUGR) and long-bone dysplasia in offspring rats, accompanied by maternal glucocorticoid over-exposure. This study is to explore whether intrauterine high glucocorticoid level can cause endochondral ossification retardation and clarify (...) its molecular mechanism in PCE fetal rats. Pregnant Wistar rats were intragastrically administered 30 and 120 mg/kg day of caffeine during gestational days (GDs) 9-20, then collected fetal serum and femurs at GD20. In vitro, primary chondrocytes were treated with corticosterone (0-1250 nM), caffeine (0-100 μM), mitogen-inducible gene 6 (Mig-6) siRNA and epidermal growth factor receptor (EGFR) siRNA, respectively, or together. Results showed that the hypertrophic chondrocytes zone (HZ) of PCE fetal

2017 Cell death & disease

75. Unstressed antepartum cardiotocography in the management of the fetus suspected of growth retardation. (Abstract)

Unstressed antepartum cardiotocography in the management of the fetus suspected of growth retardation. A detailed analysis of the antenatal cardiotocographs (CTGs) in 57 patients with suspected fetal growth retardation is presented. Four traces were normal and 53 were 'non-reactive. 'Non-reactive' traces can be sub-divided into three categories, which, in order of severity are, 'suspect', 'flat' and 'ominous'. When compared with the 'suspect' group, perinatal mortality was significantly (...) increased and the Apgar scores at one and five minutes significantly decreased in the 'flat' and 'ominous' groups. The presence of fetal distress in labour was significantly higher in the 'flat' group as compared with the 'suspect' group. Intrauterine deaths occurred only in the 'ominous' group. With experience, ten patients later in the series with 'ominous' patterns were delivered within 24 hours of the detection of such and nine infants survived. At follow-up between 6 and 34 months after birth

2014 BJOG

76. Gender-Specific Relationship Between Prenatal Exposure to Phthalates and Intrauterine Growth Restriction. Full Text available with Trip Pro

Gender-Specific Relationship Between Prenatal Exposure to Phthalates and Intrauterine Growth Restriction. No study has examined the association between prenatal phthalate exposure and intrauterine growth retardation (IUGR). This study aimed to investigate whether prenatal exposure to phthalates was associated with increased risk of IUGR.A total of 126 mother-newborn pairs, including 42 IUGR cases and 84 control newborns and their mothers, were enrolled in this case-control study. Spot urine (...) significantly inversely associated with fetal growth indicators (birth weight and Quetelet's index). When mothers were stratified by infant sex, MEHHP and MEOHP concentrations were still negatively associated with fetal growth indicators, while no significant association was observed in females. In addition, exposure-response relationships were observed between MEHHP/SumDEHP concentrations in maternal urine and IUGR.Prenatal exposure to phthalates was associated with increased risk of IUGR, and male

2014 Pediatric Research

77. Association of hereditary thrombophilia with intrauterine growth restriction Full Text available with Trip Pro

Association of hereditary thrombophilia with intrauterine growth restriction Intrauterine growth retardation (IUGR) contributes significantly to fetal morbidity and mortality, but its etiology is unknown in most cases.The aim of this study was to examine the association between inherited thrombophilia and IUGR.A case-control study was performed in a tertiary referral center (Afzalipour Hospital) over 2-years period (2010-2011). Cases (n=25) were women who had pregnancies complicated by IUDR (...) and control subjects (n=25) were women who had normal growth fetuses. All women were tested for inherited thrombophilia at least 4 weeks after delivery. Main outcome measure was prevalence of maternal thrombophlia. Genotyping for factor V Leiden, prothrombin gene (nucleotide G20210A), and MTHFR (C677T) mutation was performed by PCR technique. Protein C, S and antithrombin III activity were determined with a clotting assay (STA-Staclot, France).The prevalence of hereditary thrombophilia was 68% (n=17

2013 Iranian Journal of Reproductive Medicine

78. Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants

Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Influence of Intrauterine Growth Restriction on Amplitude-integrated EEG in Preterm Infants The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01942525 Recruitment Status : Unknown Verified September 2013 by Katrin Klebermass-Schrehof, Medical University of Vienna. Recruitment

2013 Clinical Trials

79. An approach to solving problems of growth retardation in the child and teenager. Full Text available with Trip Pro

An approach to solving problems of growth retardation in the child and teenager. The physician who looks after children and teenagers is often confronted with the problem of short stature or growth failure. Common causes of growth failure include genetic background, intrauterine disease, malnutrition, chronic illness and hormonal disorders; some cases are attributed to mental retardation or primary central nervous system disease. A major concern in the evaluation of these patients is when

1977 Canadian Medical Association Journal

80. The impact of doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth retardation. (Abstract)

The impact of doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth retardation. To test the hypothesis that earlier delivery may be warranted to improve neonatal outcome of fetuses with intrauterine growth restriction (IUGR) with abnormal Doppler parameters.This was a retrospective cohort study of 110 fetuses with an antenatal diagnosis of IUGR due to placental insufficiency which had a very low birth weight (< 1500 g), delivered

2011 Ultrasound in Obstetrics and Gynecology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>